Profilo
Rikin Mehta is the founder of Lactiga, Inc. He is currently working as a Director at Licentiam, Inc.
Posizioni attive di Rikin Mehta
| Società | Posizione | Inizio |
|---|---|---|
Licentiam, Inc.
 Licentiam, Inc. Information Technology ServicesTechnology Services Licentiam, Inc. provides information technology services. The firm engages in transforming the fragmented health and medical regulatory environment into a dynamic and integrated network, connecting practitioners and licensing boards, enabling portability and telehealth. The company was founded by Mark Vargas and Jason Reed and is headquartered in Woodbridge, NJ. | Direttore/Membro del Consiglio | - |
Lactiga, Inc.
 Lactiga, Inc. BiotechnologyHealth Technology Lactiga, Inc. operates as bio Therapeutics Company, which develops biologic to prevent mucosal infections. Its product, LCTG-001, is designed for patients with Primary Immunodeficiency Diseases (PID), including Selective IgA Deficiency (SIgAD) and Common Variable Immunodeficiency (CVID). The company was founded by Viraj Mane and Rikin Mehta and is headquartered in Toronto, Canada. | Fondatore | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 2 |
|---|---|
Licentiam, Inc.
Licentiam, Inc. Information Technology ServicesTechnology Services Licentiam, Inc. provides information technology services. The firm engages in transforming the fragmented health and medical regulatory environment into a dynamic and integrated network, connecting practitioners and licensing boards, enabling portability and telehealth. The company was founded by Mark Vargas and Jason Reed and is headquartered in Woodbridge, NJ. | Technology Services |
Lactiga, Inc.
Lactiga, Inc. BiotechnologyHealth Technology Lactiga, Inc. operates as bio Therapeutics Company, which develops biologic to prevent mucosal infections. Its product, LCTG-001, is designed for patients with Primary Immunodeficiency Diseases (PID), including Selective IgA Deficiency (SIgAD) and Common Variable Immunodeficiency (CVID). The company was founded by Viraj Mane and Rikin Mehta and is headquartered in Toronto, Canada. | Health Technology |
- Borsa valori
- Insiders
- Rikin Mehta
